Search - tctmd.com

Displaying 1 - 20 of 153

Sort: Relevancy | Date

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

News Daily News

Sotagliflozin Reduces Ischemic Risk in SCORED Analysis

Yael L. Maxwell

February 25, 2025

News Daily News

Study Links Osteoporosis Injections and Increased MACE in Dialysis Patients

L.A. McKeown

January 06, 2025

News Opinion Editor's Corner

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Shelley Wood

January 01, 2025

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

News Daily News

Going Contrast Free in TAVI Is Safe for CKD Patients

Caitlin E. Cox

August 20, 2024

News Daily News

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Michael O'Riordan

August 19, 2024

News Daily News

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

L.A. McKeown

August 05, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

Shelley Wood

May 31, 2024

News Daily News

FLOW: Semaglutide Scores Big in Diabetic Patients With CKD

L.A. McKeown

May 24, 2024

News Conference News SCAI 2024

CALORI: More Support for Eschewing Fasting Protocols Preprocedure

L.A. McKeown

May 02, 2024

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Shelley Wood

April 06, 2024

News Daily News

Patients With CKD Remain Underrepresented in Trials of CV Meds

Todd Neale

March 08, 2024

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

Shelley Wood

March 06, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Daily News

Don’t Avoid Statins in Elderly, Frail Patients: Two Retrospective Studies Argue

Yael L. Maxwell

December 15, 2023

Advertisement

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Sotagliflozin Reduces Ischemic Risk in SCORED Analysis

Study Links Osteoporosis Injections and Increased MACE in Dialysis Patients

TCTMD’s Biggest News of 2024: Stories, Videos, and More

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

TCTMD’s Top 10 Most Popular Stories for August 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Going Contrast Free in TAVI Is Safe for CKD Patients

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

August 2024 Dispatch for the CV Team

July 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for May 2024

FLOW: Semaglutide Scores Big in Diabetic Patients With CKD

CALORI: More Support for Eschewing Fasting Protocols Preprocedure

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Patients With CKD Remain Underrepresented in Trials of CV Meds

Semaglutide Winning Streak Continues in CKD With FLOW

January 2024 Dispatch for the CV Team

Don’t Avoid Statins in Elderly, Frail Patients: Two Retrospective Studies Argue

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content